More Canadian companies are remaining in Canada to grow “unicorns” (firms with a $1-billion or more valuation) rather than selling early to foreign entities, according to data in Startup Genome’s 2022 Global Startup Ecosystem Report. Meanwhile, in Atlantic Canada the number of startups slowed for the second year in a row, according to a separate report by Nova Scotia-based Entrevestor.
Organization: Deep Genomics
Opinion Leader: Canada’s early focus on artificial intelligence is starting to reap commercial benefits
Canada’s early contributions and long-standing academic expertise in artificial intelligence are now generating growing funding for and revenue in AI in drug development, but the country’s AI-enabled drug development industry faces significant challenges in coming years, Dr. Ulrik Kristensen, PhD, founder and principal analyst at UK-based Emersion Insights, says in an op-ed.
The Short Report – August 4, 2021: Ottawa’s new biomanufacturing and life sciences strategy, a national startup job board, rural transit solutions, and more
Ottawa prepares for future pandemics with launch of life science strategy, CellCAN and CCRM launch a new cell and gene therapy institute to tackle gaps in training, a new fund dedicated to developing transit solutions for rural and remote communities, and more.
Applied PeR$pectives
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
 |
Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community. |
|---|
Fast Policy Facts
 |
December 12, 2018: Requiem for a National Network Program
|
|---|
Research Money on Twitter
Loading tweets...